Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma

被引：0
|
作者：
Colomba, E. [1 ]
Alexandre, J. [2 ]
Le Teuff, G. [3 ]
Coupez, D. [4 ]
Genestie, C. [5 ]
Ray-Coquard, I. L. [6 ]
Brachet, P. E. [7 ]
Sajous, C. [8 ]
De Percin, S. [9 ]
Fabbro, M. [10 ]
Delanoy, N. [11 ]
Joly, F. [12 ]
Pautier, P. [13 ]
Frenel, J-S. [14 ]
Leary, A. [15 ]
机构：
[1] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] Hop Cochin Site Port Royal, AP HP, Oncol, Paris, France
[3] Inst Gustave Roussy, Dept Biostatist, Villejuif, France
[4] CHU Nantes Hotel Dieu, Oncol, Nantes, France
[5] Inst Gustave Roussy, Pathol, Villejuif, France
[6] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[7] Ctr Francois Baclesse, Med Oncol Dept, Caen, France
[8] Inst Cancerol Hosp Civils Lyon IC HCL, Med Oncol Dept, Lyon, France
[9] Hop Univ Paris Ctr Med Oncol, Hop Cochin, Paris, France
[10] Inst Canc Montpellier, Dept Med Oncol, Montpellier, France
[11] Hop European George Pompidou, Dept Med Oncol, Paris, France
[12] Ctr Francois Baclesse, Med Oncol, Caen, France
[13] Inst Gustave Roussy, Dept Med, Villejuif, France
[14] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Med Oncol, Saint Herblain, France
[15] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
801P
引用
收藏
页码：S763 / S763
页数：1
相关论文
共 50 条
  • [21] High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
    Gatalica, Zoran
    Vranic, Semir
    Xiu, Joanne
    Swensen, Jeffrey
    Reddy, Sandeep
    FAMILIAL CANCER, 2016, 15 (03) : 405 - 412
  • [22] First-line combined Checkpoint Blockade in Patents with MSI-H/dMMR mCRC
    Klein, Friederike
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (04): : 562 - 562
  • [23] Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.
    Kawazoe, Akihito
    Shitara, Kohei
    Noguchi, Masaaki
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [24] Infrequent microsatellite instability - High (MSI-H) in pancreatitis and pancreatic cancer specimens.
    Ahn, MS
    Doctolero, RT
    Pham, TTT
    Behling, CA
    Binmoeller, K
    Carethers, JM
    GASTROENTEROLOGY, 2000, 118 (04) : A1378 - A1378
  • [25] Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
    Barata, Pedro
    Agarwal, Neeraj
    Nussenzveig, Roberto
    Gerendash, Benjamin
    Jaeger, Ellen
    Hatton, Whitley
    Ledet, Elisa
    Lewis, Brian
    Layton, Jodi
    Babiker, Hani
    Bryce, Alan
    Garje, Rohan
    Stein, Cy
    Kiedrowski, Lesli
    Saylor, Philip
    Sartor, Oliver
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [26] Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
    Neelima Vidula
    Andrew Lipman
    Shumei Kato
    Caroline Weipert
    Katherine Hesler
    Georges Azzi
    Ahmed Elkhanany
    Dejan Juric
    Estelamari Rodriguez
    Colleen Faulkner
    Paul Makhlouf
    Kristin Price
    Joyce O’Shaughnessy
    Aditya Bardia
    npj Breast Cancer, 8
  • [27] Microsatellite instability and sensitivity to fluoropyrimidine and oxaliplatin containing first-line chemotherapy in metastatic colorectal cancer
    Liu, Jia
    Wang, Biao
    Fang, Wentong
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (05) : 267 - 270
  • [28] Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
    Vidula, Neelima
    Lipman, Andrew
    Kato, Shumei
    Weipert, Caroline
    Hesler, Katherine
    Azzi, Georges
    Elkhanany, Ahmed
    Juric, Dejan
    Rodriguez, Estelamari
    Faulkner, Colleen
    Makhlouf, Paul
    Price, Kristin
    O'Shaughnessy, Joyce
    Bardia, Aditya
    NPJ BREAST CANCER, 2022, 8 (01)
  • [29] Phase 3, open-label, randomized study of first-line pembrolizumab (pembro) vs investigator choice chemotherapy for mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal carcinoma (mCRC): KEYNOTE-177.
    Diaz, Luis A.
    Le, Dung T.
    Yoshino, Takayuki
    Andre, Thierry
    Bendell, Johanna C.
    Koshiji, Minori
    Zhang, Yinghua
    Kang, S. Peter
    Lam, Bao
    Jaeger, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Platinum rechallenge in second line chemotherapy for metastatic endometrial carcinoma
    Souza, R.
    Saito, A.
    Sanches, S.
    Guimaraes, A.
    Ribeiro, A.
    Da Costa, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S551 - S551
12345